The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis.

Cenk Sunu Ahmet Kursad Gunes Gulten Korkmaz Akat Yasin Kalpakçı Funda Ceran Simten Dagdas Gülsüm Özet

Published in: Revista da Associacao Medica Brasileira (1992) (2021)

Although our results are generally in line with the published data, some divergence from previous results has been observed with respect to risk factors for thrombotic events. Absence of a correlation between leukocytosis and thrombosis may be related with the significant decline in white blood cells after treatment. Also, a significant reduction in platelet counts occurring in association with treatment is linked with a lowered incidence of thrombosis. Janus Kinase 2-positive patients had a similar thrombosis frequency with that reported in the literature.

Keyphrases

pulmonary embolism
end stage renal disease
induced apoptosis
newly diagnosed
ejection fraction
chronic kidney disease
risk factors
peritoneal dialysis
cell cycle arrest
randomized controlled trial
signaling pathway
cell proliferation
tyrosine kinase
cell death
endoplasmic reticulum stress
data analysis